Prismaccess contains a comprehensive, detailed record of HTA authorities’ decisions extracted into easy to navigate summaries.
Prismaccess allows you to identify key data and comparator products performances allowing you to build your Pricing & Reimbursement dossier in accordance with the needs of the regulators and payers.
Prismaccess provides data and information on all pharma & biotech products during initial and subsequent evaluations by national authorities on HTA markets.
MARKET ACCESS decision makers, HEOR departments, R&D managers, BUSINESS & DEV directors, your satisfaction is our success.
We provide insight to 9 out of 10 largest pharma companies, medium and small pharma and biotechs, finance and insurance companies, institutions and government agencies.